Clinical Trial Update: Giving Epstein-Barr Virus (EBV) Specific Killer T Lymphocytes to Patients Who Have Had Donor Marrow Grafts [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated infusion of Epstein-Barr virus–specific killer T lymphocytes in patients who have had donor marrow transplants. The study status is co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epstein-barr Virus Infections

Drugs mentioned

• EBV-specific killer T lymphocytes

Snippet

Sponsor: Baylor College of Medicine | Conditions: Epstein-Barr Virus Infections | Phase 1 | Status: COMPLETED